Double-blind, placebo-controlled study to assess safety and efficacy of riluzole as a neuroprotective drug in patients with early, untreated Parkinson's disease

被引：0
|
作者：
Hunter, C
Jankovic, J
机构：
来源：
NEUROLOGY | 1999年 / 52卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A214 / A215
页数：2
相关论文
共 50 条
  • [1] A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson's disease
    Jankovic, J
    Hunter, C
    PARKINSONISM & RELATED DISORDERS, 2002, 8 (04) : 271 - 276
  • [2] Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial
    Mcgarry, Andrew
    Rosanbalm, Shane
    Leinonen, Mika
    Olanow, Warren
    To, Dennis
    Bell, Adam
    Lee, Daniel
    Chang, Jamie
    Dubow, Jordan
    Dhall, Rohit
    Burdick, Daniel
    Parashos, Sotirios
    Feuerstein, Jeanne
    Quinn, Joseph
    Pahwa, Rajesh
    Afshari, Mitra
    Ramirez-Zamora, Aldolfo
    Chou, Kelvin
    Tarakad, Arjun
    Luca, Corneliu
    Klos, Kevin
    Bordelon, Yvette
    St Hiliare, Marie-Helene
    Shprecher, David
    Lee, Seulki
    Dawson, Ted M.
    Roschke, Viktor
    Kieburtz, Karl
    LANCET NEUROLOGY, 2024, 23 (01): : 37 - 45
  • [3] A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Efficacy of NLY01 in Early Untreated Parkinson's Disease
    Roschke, Viktor
    Dawson, Ted
    Bell, Adam
    Olanow, C. Warren
    Kieburtz, Karl
    McGarry, Andrew
    MOVEMENT DISORDERS, 2023, 38 : S1 - S2
  • [4] Effect of riluzole on dyskinesia and duration of the ON state in Parkinson disease patients - A double-blind placebo-controlled pilot study
    Braz, CA
    Borges, V
    Ferraz, HB
    CLINICAL NEUROPHARMACOLOGY, 2004, 27 (01) : 25 - 29
  • [5] A multicenter, double-blind, placebo-controlled study to assess efficacy and safety of entacapone in Korean patients with Parkinson's disease experiencing end-of-dose deterioration
    Im, JH
    Jeon, BS
    Lee, MS
    Lee, WY
    Kim, JW
    Lee, MC
    MOVEMENT DISORDERS, 2002, 17 : S40 - S40
  • [6] Efficacy and safety of rotigotine transdermal patch in Chinese patients with early-stage Parkinson's disease: A randomized, double-blind, placebo-controlled study
    Zhang, Z.
    Asgharnejad, M.
    Du, X.
    Surmann, E.
    Bauer, L.
    MOVEMENT DISORDERS, 2015, 30 : S137 - S138
  • [7] Efficacy and safety of rasagiline monotherapy in Japanese patients with early Parkinson's disease: A phase 3, randomized, double-blind, placebo-controlled, multicenter study
    Hattori, N.
    Takeda, A.
    Takeda, S.
    Nishimura, A.
    Kitagawa, T.
    Mochizuki, H.
    Nagai, M.
    Takahashi, R.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 231 - 232
  • [8] Efficacy and safety of rasagiline in Chinese patients with early Parkinson's disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study
    Zhang, Zhenxin
    Wang, Jian
    Chen, Shengdi
    Liu, Chunfeng
    Zhang, Baorong
    Peng, Rong
    Sun, Shenggang
    Sun, Xiangru
    Zhao, Gang
    Qu, Qiumin
    Li, Yansheng
    Zhu, Suiqiang
    Pan, Xiaoping
    Shao, Ming
    Wang, Yanping
    TRANSLATIONAL NEURODEGENERATION, 2018, 7
  • [9] Efficacy and safety of rasagiline in Chinese patients with early Parkinson’s disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study
    Zhenxin Zhang
    Jian Wang
    Shengdi Chen
    Chunfeng Liu
    Baorong Zhang
    Rong Peng
    Shenggang Sun
    Xiangru Sun
    Gang Zhao
    Qiumin Qu
    Yansheng Li
    Suiqiang Zhu
    Xiaoping Pan
    Ming Shao
    Yanping Wang
    Translational Neurodegeneration, 7
  • [10] Efficacy of double-blind, placebo-controlled pramipexole against depression in Parkinson's disease
    Barone, P.
    Poewe, W.
    Tolosa, E.
    Rascol, O.
    Massey, D.
    Debieuvre, C.
    Albrecht, S.
    MOVEMENT DISORDERS, 2009, 24 : S347 - S347
12345